Vontobel Holding
ABBV icon

Vontobel Holding’s AbbVie ABBV Stock Holding History

Vontobel Holding’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.2M Buy
170,914
+25,190
+17% +$5.59M 0.13% 151
2025
Q4 		$33.3M Buy
145,724
+2,988
+2% +$681K 0.1% 158
2025
Q3 		$33M Buy
142,736
+396
+0.3% +$80.6K 0.1% 145
2025
Q2 		$26.4M Buy
142,340
+7,900
+6% +$1.47M 0.08% 163
2025
Q1 		$28.2M Buy
134,440
+3,841
+3% +$747K 0.1% 138
2024
Q4 		$23.2M Sell
130,599
-4,079
-3% -$750K 0.08% 148
2024
Q3 		$26.6M Buy
134,678
+2,087
+2% +$390K 0.09% 145
2024
Q2 		$22.7M Sell
132,591
-35,099
-21% -$5.81M 0.07% 149
2024
Q1 		$30.5M Sell
167,690
-20,138
-11% -$3.47M 0.24% 107
2023
Q4 		$29.1M Sell
187,828
-2,895
-2% -$422K 0.24% 107
2023
Q3 		$28.4M Sell
190,723
-20,233
-10% -$2.97M 0.26% 98
2023
Q2 		$28.4M Sell
210,956
-91
-0% -$13.3K 0.25% 99
2023
Q1 		$33.6M Buy
211,047
+21,056
+11% +$3.22M 0.31% 86
2022
Q4 		$30.8M Sell
189,991
-15,931
-8% -$2.44M 0.31% 86
2022
Q3 		$27.6M Buy
205,922
+38,043
+23% +$5.46M 0.32% 81
2022
Q2 		$25.9M Sell
167,879
-7
-0% -$1.07K 0.28% 84
2022
Q1 		$27.5M Sell
167,886
-64,487
-28% -$9.37M 0.24% 97
2021
Q4 		$31.6M Sell
232,373
-27,381
-11% -$3.23M 0.26% 86
2021
Q3 		$28M Buy
259,754
+33,389
+15% +$3.82M 0.25% 90
2021
Q2 		$25.4M Sell
226,365
-8,146
-3% -$917K 0.22% 97
2021
Q1 		$25.4M Buy
234,511
+53,279
+29% +$5.7M 0.19% 78
2020
Q4 		$19.4M Buy
+181,232
New +$17.4M 0.13% 117

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vontobel Holding's ABBV Position: Q1 2026 in Review

Vontobel Holding increased its AbbVie (ABBV) stake by 17% in Q1 2026, buying an estimated $5.59M and bringing the position to 170,914 shares worth $37.2M. The position accounts for 0.13% of the portfolio, ranked #151.

Vontobel Holding first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Vontobel Holding held 170,914 shares of AbbVie worth $37.2M as of Q1 2026.
  • Vontobel Holding bought 25,190 AbbVie shares in Q1 2026, an estimated $5.59M.
  • AbbVie made up 0.13% of Vontobel Holding's portfolio in Q1 2026, its #151 holding.
  • Vontobel Holding first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.